Rapid Communications in Mass Spectrometry · 2010 · 33 citations · 18 references
PharmacyBiochemistryImmunologyAnalytical ChemistryMass Spectrometric AnalysisMonoclonal AntibodiesAntibody CharacterizationChromatographic CouplingMass SpectrometryMass Spectrometry Data AnalysisPeptide AnalysisBackbone Cleavage MechanismsBiopharmaceutical Downstream ProcessingElectron Transfer DissociationFragmentation PathwaysMass Spectrometric DetectionPeptide Mass SpectrometryTandem Mass SpectrometryTandem Mass Spectrometry Analysis
Aspartic acid formed by nonenzymatic deamidation of asparagine often isomerizes to isoaspartic acid through a succinimide intermediate. Accumulation of isoaspartic acid initiates aggregation and degradation in proteins. Deamidation at the antigen-binding region reduces the efficacy and also upregulates immunogenicity of monoclonal antibodies. We report an improved 'bottom-up' tandem mass spectrometric method to detect and decipher the position of isoaspartate formation in therapeutic immunoglobulin gamma in a single chromatographic run. Differentiation between aspartate and isoaspartate residues through collision-induced tandem mass spectrometry is formidable due to their identical mass. Signature backbone cleavage ions, c(n) + 57 and z(l-n) - 57, produced upon radical-mediated fragmentation, were used to delineate the site of isomerization. It is more conclusive than monitoring the relative peak intensity and the decrease in hydrophobicity of the isoaspartate-containing peptide in a chromatographic elution. Collectively, this methodology provides a useful tool to monitor deamidation and isomerization in biopharmaceuticals during their production, downstream processing and storage.
18
In Vivo Deamidation Characterization of Monoclonal Antibody by LC/MS/MS
Lihua Huang, Jirong Lu, Victor J. Wroblewski et al. · Analytical Chemistry · 2005 · 265 citations